logo
Samuel I. Rapaport, creator of the partial thromboplastin time and other landmark blood coagulation discoveries: 19 November 1921–20 December 2011
The unique contribution of ion channels to platelet and megakaryocyte function
Activated protein C: reasons to believe
Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
Influence of recent immobilization and recent surgery on mortality in patients with pulmonary embolism
The relationship between body mass index, activated protein C resistance and risk of venous thrombosis
Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study
Interobserver reliability of compression ultrasound for residual thrombosis after first unprovoked deep vein thrombosis
Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism
A phenotype–genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom
Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice
The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1 a1 domain of FVIII
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis
Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate
Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model
The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells
Type II antithrombin deficiency caused by a large in-frame insertion: structural, functional and pathological relevance
Identification of Hic-5 as a novel regulatory factor for integrin αIIbβ3 activation and platelet aggregation in mice
Transmembrane domains are critical to the interaction between platelet glycoprotein V and glycoprotein Ib-IX complex
Protein kinase Cε and protein kinase CΘ double-deficient mice have a bleeding diathesis
Tissue factor-Akt signaling triggers microvessel formation
Mobilization of CD34+KDR+ endothelial progenitor cells predicts target lesion revascularization
Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential
Shear stress is required for the endocytic uptake of the factor VIII-von Willebrand factor complex by macrophages
Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity
The C-terminus of tissue factor pathway inhibitor α is required for its interaction with factors V and Va
Switching patients from clopidogrel to prasugrel in acute coronary syndrome: effects of prasugrel loading dose on residual platelet reactivity
On aspirin treatment but not baseline thromboxane B2 levels predict adverse outcomes in patients with acute coronary syndromes
Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening
Searching for the role of primary prophylaxis in preventing inhibitor development in hemophilia A
Observations regarding the immunogenicity of BDD-rFVIII derived from a mechanistic personalized medicine perspective
P2X7 regulation of macrophage tissue factor activity and microparticle generation
Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia
More on: optimal dose for stroke thrombolysis in Asians
Heparin concentrations in neonates during cardiopulmonary bypass: a rebuttal
Thrombolysis for normotensive patients with acute symptomatic pulmonary embolism: a rebuttal
Thrombolysis for normotensive patients with acute symptomatic pulmonary embolism: reply to a rebuttal
Join ISTH